Showing results (861-870 of 4,625) with videos related to
Sort By:
Pageof 463
Journal of Neuroinflammation|January 25, 2017
Rab32 connects ER stress to mitochondrial defects in multiple sclerosisYohannes Haile, Xiaodan Deng, Carolina Ortiz-Sandoval, et al.Journal of Neuroinflammation|January 25, 2017
Cerebral ischemic damage in diabetes: an inflammatory perspectiveVibha Shukla, Akhalesh Kumar Shakya, Miguel A Perez-Pinzon, et al.Journal of Neuroinflammation|January 15, 2017
Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activatorSven Micklisch, Yuchen Lin, Saskia Jacob, et al.Journal of Neuroinflammation|January 15, 2017
Microglial activation in Parkinson's disease using [18F]-FEPPAChristine Ghadery, Yuko Koshimori, Sarah Coakeley, et al.Journal of Neuroinflammation|January 15, 2017
Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitisEllen Merckx, Giulia Albertini, Magdalena Paterka, et al.Journal of Neuroinflammation|January 15, 2017
Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesityLivia B Pascoal, Bruna Bombassaro, Albina F Ramalho, et al.Journal of Neuroinflammation|April 15, 2017
Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcoholPallavi Shrivastava, Miguel A Cabrera, Lucy G Chastain, et al.Journal of Neuroinflammation|October 19, 2018
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapyJiawen Qian, Chen Wang, Bo Wang, et al.Journal of Neuroinflammation|September 29, 2016
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrierSlava Rom, Viviana Zuluaga-Ramirez, Nancy L Reichenbach, et al.Journal of Neuroinflammation|February 1, 2014
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumabXenia Kobeleva, Florian Wegner, Inez Brunotte, et al.Pageof 463